Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (241-250 of 587) with videos related to

Pageof 59
Sort By:
Clinical Chemistry and Laboratory Medicine|July 26, 2018
The global impact of the International Federation of Clinical Chemistry and Laboratory Medicine, Education and Management Division: engaging stakeholders and assessing HbA1c quality in a multicentre study across ChinaEmma English, Cas Weykamp, Linong Ji, et al.
Clinical Medicine Insights. Cardiology|May 7, 2013
Unique and Varied Contributions of Traditional CVD Risk Factors: A Systematic Literature Review of CAD Risk Factors in ChinaJoanne Foody, Yong Huo, Linong Ji, et al.
Journal of Diabetes and Its Complications|March 19, 2015
Increasing body mass index identifies Chinese patients with type 2 diabetes mellitus at risk of poor outcomesLinong Ji, Dajin Zou, Li Liu, et al.
Nature Medicine|May 25, 2023
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trialLeili Gao, Byung Wan Lee, Manoj Chawla, et al.
Plos One|February 13, 2015
ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study)Qionghong Xie, Chuan-Ming Hao, Linong Ji, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2025
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T StudyRobert Ritzel, Melanie J Davies, Lichen Hao, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 22, 2021
A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World ExperienceTianshu Zeng, Huijuan Yuan, Jiangong Ren, et al.
Endocrine|August 14, 2014
Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysisFeng Sun, Shanshan Wu, Shuxia Guo, et al.
Diabetes, Obesity & Metabolism|May 11, 2026
Distribution of HbA1c Levels in Patients With GCK-MODY: A Worldwide Literature-Based Retrospective AnalysisYihan Zhao, Tianhao Ba, Yinkun Yan, et al.
Diabetes, Obesity & Metabolism|March 10, 2026
Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLDYuanping Shi, Qi Huang, Yingning Liu, et al.
Pageof 59

Showing results (241-250 of 587) with videos related to

Sort By:
Pageof 59
Clinical Chemistry and Laboratory Medicine|July 26, 2018
The global impact of the International Federation of Clinical Chemistry and Laboratory Medicine, Education and Management Division: engaging stakeholders and assessing HbA1c quality in a multicentre study across ChinaEmma English, Cas Weykamp, Linong Ji, et al.
Clinical Medicine Insights. Cardiology|May 7, 2013
Unique and Varied Contributions of Traditional CVD Risk Factors: A Systematic Literature Review of CAD Risk Factors in ChinaJoanne Foody, Yong Huo, Linong Ji, et al.
Journal of Diabetes and Its Complications|March 19, 2015
Increasing body mass index identifies Chinese patients with type 2 diabetes mellitus at risk of poor outcomesLinong Ji, Dajin Zou, Li Liu, et al.
Nature Medicine|May 25, 2023
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trialLeili Gao, Byung Wan Lee, Manoj Chawla, et al.
Plos One|February 13, 2015
ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study)Qionghong Xie, Chuan-Ming Hao, Linong Ji, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2025
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T StudyRobert Ritzel, Melanie J Davies, Lichen Hao, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 22, 2021
A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World ExperienceTianshu Zeng, Huijuan Yuan, Jiangong Ren, et al.
Endocrine|August 14, 2014
Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysisFeng Sun, Shanshan Wu, Shuxia Guo, et al.
Diabetes, Obesity & Metabolism|May 11, 2026
Distribution of HbA1c Levels in Patients With GCK-MODY: A Worldwide Literature-Based Retrospective AnalysisYihan Zhao, Tianhao Ba, Yinkun Yan, et al.
Diabetes, Obesity & Metabolism|March 10, 2026
Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLDYuanping Shi, Qi Huang, Yingning Liu, et al.
Pageof 59